| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 06/10/1992 | EP0489711A2 Method for producing human growth hormone |
| 06/10/1992 | EP0489138A1 Vaccine composition for treating human chlamydial diseases. |
| 06/09/1992 | US5120649 Photodynamic inactivation of viruses in blood cell-containing compositions |
| 06/09/1992 | CA1303295C Immunosuppressor and method of extraction thereof |
| 06/09/1992 | CA1302927C Efomycin g, its preparation and its use as a yield promoter in animals |
| 06/09/1992 | CA1302926C Antibiotic f-0769, process for its production, and its use as a growthaccelerating and feed efficiency increasing agent and as an antitumour agent |
| 06/09/1992 | CA1302881C Calcium channel modulating substances |
| 06/09/1992 | CA1302879C Composition having reduced nephrotoxicity comprising a fatty acid containing component and cyclosporine |
| 06/08/1992 | CA2056970A1 Antitumoral and antiviral compound |
| 06/03/1992 | EP0488622A2 Squamous cell carcinoma-like immunoreactive antigen from human female urine |
| 06/03/1992 | EP0488583A2 Improved kit and method for administration of bacillus calmette-guerin |
| 06/03/1992 | EP0487603A1 Composition based on hydrated lipidic lamelar phases or on liposomes containing at least one derivative of labdane, or a plant extract containing it; cosmetic or pharmaceutical, particularly dermatological composition containing it. |
| 06/03/1992 | EP0487587A1 Recombinant retroviruses delivering vector constructs to target cells |
| 06/03/1992 | CN1061529A Technology method of drone refind produsts |
| 06/02/1992 | US5118493 Composition having reduced nephrotoxocity comprising a fatty acid containing component and cyclosporine |
| 06/02/1992 | CA1302324C Ex vivo effector cell activation for target cell killing |
| 05/29/1992 | WO1992009294A1 Proteins purified from mammalian gestational tissue which control cell proliferation |
| 05/29/1992 | WO1992008789A1 Measles virus recombinant poxvirus vaccine |
| 05/29/1992 | WO1992008487A1 Recombinant feline coronavirus s proteins |
| 05/29/1992 | WO1992008472A1 Antithrombosis agents |
| 05/29/1992 | WO1992008471A1 Method for determining the sensitivity and/or specificity of an assay system for detecting antibodies |
| 05/29/1992 | WO1992008448A1 Method for preventing drug-induced or radiation myelosuppression |
| 05/29/1992 | CA2101759A1 Antithrombosis agents |
| 05/29/1992 | CA2074476A1 Proteins purified from mammalian gestational tissue which control cell proliferation |
| 05/29/1992 | CA2055715A1 Kit and method for administration of bacillus calmette-guerin |
| 05/27/1992 | EP0487512A1 Production of heterodimeric human fertility hormones |
| 05/27/1992 | EP0487404A1 External dermatological composition |
| 05/27/1992 | EP0486584A1 Dopaminergic neurotrophic factor for treatment of parkinson's disease |
| 05/27/1992 | EP0217816B1 Elastin-based product, method for the preparation thereof and biological application thereof, particularly as biomaterials and artificial supports |
| 05/26/1992 | US5116963 Anticoagulants |
| 05/26/1992 | US5116624 Efa compositions and therapy |
| 05/26/1992 | US5116617 Pharmaceutical composition for topical use in the treatment of the capillary fragility |
| 05/26/1992 | US5116614 Jomol derivatives as agents for the use in malignant tumors and lowered immune defenses |
| 05/26/1992 | US5116494 Artificial pancreatic perfusion device with temperature sensitive matrix |
| 05/26/1992 | CA1301689C Method for selectively increasing the ratio of single major components ofantibiotic a 16686 complex |
| 05/21/1992 | CA2096633A1 Measles virus recombinant poxvirus vaccine |
| 05/20/1992 | EP0486480A2 Centrifugal processing apparatus |
| 05/20/1992 | EP0347448B1 Aqueous preparation based on mineral salts and acetic acid for the prevention and treatment of viral diseases |
| 05/20/1992 | EP0248057B1 Glucose tolerance factor and method of making same |
| 05/20/1992 | CN1061156A Production process method of cardio-cerebral beniol injection |
| 05/19/1992 | US5114848 Prepared from bifidobacterium; immunomodulating properties |
| 05/19/1992 | US5114847 Fusion with cytoplasm from transformed cells; hybridomas |
| 05/19/1992 | US5114844 Immunoassay with a protein or antibody |
| 05/19/1992 | US5114722 Medicament from peyer's patches |
| 05/19/1992 | US5114721 Lymphocytes activated by exposure to antigen and surface treated with photoactive psoralen crosslinking agent |
| 05/19/1992 | US5114396 Method of washing blood cells and container assembly thereof |
| 05/15/1992 | WO1992008470A1 Anti-inflammatory composition derived from emu oil |
| 05/15/1992 | CA2096242A1 Anti-inflammatory composition derived from emu oil |
| 05/14/1992 | WO1992007943A1 Retroviral vectors useful for gene therapy |
| 05/14/1992 | WO1992007877A1 Hair growth regulating composition comprising epithelium cell supernatant-derived growth factor |
| 05/14/1992 | WO1992007615A1 A bioartificial liver |
| 05/14/1992 | WO1992007575A1 Antimicrobial composition |
| 05/14/1992 | WO1992007573A1 Genetic modification of endothelial cells |
| 05/14/1992 | WO1992007572A1 Agents and methods for binding to elam-1 |
| 05/14/1992 | CA2095256A1 Retroviral vectors useful for gene therapy |
| 05/14/1992 | CA2094911A1 Agents and methods for binding to elam-1 |
| 05/13/1992 | EP0484519A1 Process for lyophilizing cells, cell-like materials and platelets in a mixture of biocompatible amphipathic polymers |
| 05/13/1992 | EP0484517A1 Venting system. |
| 05/13/1992 | EP0484512A1 Human peripheral blood cells in an immunocompromised host |
| 05/13/1992 | EP0429645A4 Reducing the spread of infection by blood handling equipment |
| 05/13/1992 | EP0260280B1 Immunoselection method |
| 05/12/1992 | US5112872 Antispasmodic agent |
| 05/12/1992 | CA1300503C Immunological adjuvant |
| 05/10/1992 | WO1992008804A1 Erythrocytes and thrombo-erythrocytes as target specific agents |
| 05/10/1992 | CA2095925A1 Erythrocytes and thrombo-erythrocytes as target specific abents |
| 05/10/1992 | CA2055177A1 Porcine seroconversion panels |
| 05/08/1992 | WO1992008348A1 Red blood cell storage solution |
| 05/07/1992 | WO1992007656A2 System and method for processing biological fluids |
| 05/06/1992 | EP0483765A2 Method for activating lymphocyte |
| 05/06/1992 | EP0483597A2 Process of preparation of carebastin |
| 05/06/1992 | EP0483304A1 Method of inactivation of viral and bacterial blood contaminants |
| 05/06/1992 | EP0483281A1 Recombinant human thyroid peroxidase |
| 05/06/1992 | EP0483248A1 Riboflavin composition and method for production |
| 05/06/1992 | EP0299082B1 Antiviral agent |
| 05/06/1992 | CN1060785A Natural anti-cancer leukonuclein made from animal spleens |
| 05/05/1992 | CA1300059C Antibiotic vermisporin, process for the production thereof and pharmaceutical composition comprising it as an active antibacterial agent |
| 05/05/1992 | CA1300058C Process for preparing activated killer cells |
| 05/05/1992 | CA1300010C Hepatocyte growth factor |
| 05/01/1992 | WO1992007581A1 Methods and compositions for suppressing allograft rejection in mammals |
| 04/30/1992 | WO1992006702A1 A method for transplanting cells into the brain and therapeutic uses therefor |
| 04/30/1992 | WO1992006696A1 Method for obtaining bioactive preparation from blood |
| 04/30/1992 | WO1992006677A1 Artificial viral envelopes |
| 04/30/1992 | WO1992006666A1 Dna gel stabilized thermal water liposomes |
| 04/30/1992 | DE4033996A1 Capsules for normalising intestinal flora - contg. freeze-dried Lactobacillus and Bifidobacterium cultures |
| 04/29/1992 | EP0483113A2 A method of producing an enzymatically active polypeptide analog of human Cu/Zn SOD |
| 04/29/1992 | EP0482530A2 Composition for the regulation of intestinal flora |
| 04/29/1992 | EP0482228A1 A method of producing cholesterol free egg products with an extended refrigerated shelf-life and products produced thereby |
| 04/29/1992 | EP0482018A1 Toxin uses |
| 04/29/1992 | EP0092574B1 Oligonucleotide therapeutic agent and methods of making same |
| 04/29/1992 | CN1060605A Making method of strong thrombus-dissolving capsule |
| 04/29/1992 | CN1060601A Making method of antidote |
| 04/28/1992 | US5108760 Enhances lak cell activation by treatment of human peripheral blood mononuclear cells with amino acid amides |
| 04/28/1992 | US5108748 Method of treatment during withdrawal from alcohol dependency |
| 04/28/1992 | US5108612 Method and a device for the selective elimination of plasma components from blood |
| 04/28/1992 | CA2054239A1 Process for the preparation of carebastine |
| 04/28/1992 | CA1299752C Optical decoding technique for speech recognition |
| 04/28/1992 | CA1299551C Particle separation process |
| 04/28/1992 | CA1299508C Human pancreatic elastase i |
| 04/28/1992 | CA1299507C Grf analogs |
| 04/22/1992 | EP0481148A1 Pharmaceutical compositions, process for obtaining them and their use as antitumor agents |